Literature DB >> 30312650

Detection of antibodies against Aggregatibacter actinomycetemcomitans in serum and saliva through ELISA in periodontally healthy individuals and individuals with chronic periodontitis.

Nikita B Gadekar1, Jagadish V Hosmani2, Kishore G Bhat3, Vijayalakshmi S Kotrashetti1, Ramakant S Nayak1, Deepa V Babji1, Smita M Pattanshetty1, Vinayak M Joshi4, Rani A Bansode3.   

Abstract

BACKGROUND: Periodontitis is a persistent polymicrobial infection, which leads to chronic inflammation in the tooth supporting tissues. Aggregatibacter actinomycetemcomitans are normal commensals of oral cavity but are low in number in periodontally healthy subjects. They are one of the major pathogens aetiologically linked to periodontal disease. Plasma and salivary antibody measurement may be useful to support diagnosis, disease activity, classification and prognosis of periodontitis. The aim of the present study was to investigate the association between the serum and salivary antibody levels to A. actinomycetemcomitans and therefore, to find whether this association was varying in different grades of periodontitis.
METHOD: Total of 50 periodontally healthy and 50 chronic periodontitis subjects (35-65 years) of both sexes were included for the study. 2 ml of un-stimulated saliva and 5 ml of venous blood was collected under sterile conditions. The detection of antibodies against A. actinomycetemcomitans in periodontally healthy individuals and individuals with chronic periodontitis was performed using indirect ELISA.
RESULTS: Results showed serum IgG, IgA mean levels against A. actinomycetemcomitans were higher in chronic periodontitis subjects compared to mean levels in periodontally healthy subjects. Similarly, salivary IgG, IgA levels were also raised in chronic periodontitis patients as compared in healthy subjects. Also the mean levels of serum IgG and salivary IgA were increased as the severity of disease increased.
CONCLUSION: Antibody titer using saliva and serum could be useful tool for screening of patients with chronic periodontitis. Further, monitoring the various phases of treatment outcome using saliva could be a useful, non-invasive, prognostic indicator.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Immunology; Pathogenesis of periodontal diseases; Periodontitis; Prognosis; Saliva

Mesh:

Substances:

Year:  2018        PMID: 30312650     DOI: 10.1016/j.micpath.2018.10.007

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  4 in total

1.  Aggregatibacter actinomycetemcomitans: From Basic to Advanced Research.

Authors:  Abdelhadi Hbibi; Amal Bouziane; Badiaa Lyoussi; Mimoun Zouhdi; Driss Benazza
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Oral Microbiota Composition and Antimicrobial Antibody Response in Patients with Recurrent Aphthous Stomatitis.

Authors:  Zuzana Stehlikova; Vojtech Tlaskal; Natalie Galanova; Radka Roubalova; Jakub Kreisinger; Jiri Dvorak; Petra Prochazkova; Klara Kostovcikova; Jirina Bartova; Marketa Libanska; Radka Cermakova; Dagmar Schierova; Antonin Fassmann; Petra Borilova Linhartova; Stepan Coufal; Miloslav Kverka; Lydie Izakovicova-Holla; Jitka Petanova; Helena Tlaskalova-Hogenova; Zuzana Jiraskova Zakostelska
Journal:  Microorganisms       Date:  2019-12-01

3.  The Expression of miR-34a in Gingival Crevicular Fluid of Chronic Periodontitis and Its Connection with the TLR/NF-κB Signaling Pathway.

Authors:  Jiaxin Pan; Jue Liu; Lu Zhao
Journal:  Appl Bionics Biomech       Date:  2022-08-16       Impact factor: 1.664

4.  Association among serum and salivary A. actinomycetemcomitans specific immunoglobulin antibodies and periodontitis.

Authors:  Gaetano Isola; Alessandro Polizzi; Romeo Patini; Sebastiano Ferlito; Angela Alibrandi; Giuseppe Palazzo
Journal:  BMC Oral Health       Date:  2020-10-15       Impact factor: 2.757

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.